3576 results for «2371»

Filter By

3576 results

EuroPCR 2021 Clinical Research - Waiting for a new meta-analysis of revascularisation versus medical therapy for chronic coronary syndromes: what should we be focusing on?

12 May 2021 – From EuroPCR 2021

Revascularisation vs. medical therapy alone for chronic coronary syndromes: has the issue been settled ? Follow this PCR Clinical Research episode to understand the new findings from the latest meta-analysis!

PCR Clinical Research - Waiting for a new meta-analysis of revascularisation versus medical therapy

Complete revascularisation in patients with acute myocardial infarction

18 May 2021 – From EuroPCR 2021

Watch this session presented by Piroth Zsolt in order to get a quick update on the latest most significant evidence in physiology guided PCI in patients with acute MI, to have a recommendation from an expert on how this assessment can be implemented today compatibly with a IIa...

Complete revascularisation in patients with acute myocardial infarction

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Andreas Baumbach and Patrick W. Serruys in order to understand what is a healing-targeted (HT) drug-eluting stent (DES) and what are the potential benefits, to review recent clinical data of the HT DES from the PIONEER III trial, and to learn about...

What is a healing-targeted drug-eluting stent and how is it different to a normal stent?

Patent foramen ovale (PFO) closure with stroke

18 May 2021 – From EuroPCR 2021

Watch this session presented by Engin Bozkurt in order to know more about incidence about stroke caused to younger people, to follow the guideline trend towards patent foramen ovale (PFO) closure, and to learn the future of PFO and device trends.

Patent foramen ovale (PFO) closure with stroke

Improving your patient's outcomes with the Edwards Benchmark program

18 May 2021 – From EuroPCR 2021

Watch this session presented by Hélène Eltchaninoff in order to understand the benefit of delivering a standardised care pathway to consistently achieve excellent outcomes, to improve access to high quality of care with safe early discharge for selected patients, in Europe, and to learn how the Edwards Benchmark...

Improving your patient's outcomes with the Edwards Benchmark program

A picture is worth a thousand words: how intravascular imaging can enhance the continuum of care

18 May 2021 – From EuroPCR 2021

Watch this session presented by Giulio Guagliumi and Tina Vilsbøll in order to understand how intravascular imaging can assess patient risk factors, how referring physicians can utilize and patients can benefit from an imaging-guided intervention, and how IVUS+NIRS images can be used as a tool to enhance patient education...

A picture is worth a thousand words: how intravascular imaging can enhance the continuum of care

Can a pressure guidewire expand coronary physiology adoption in bifurcations?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Evald Hoi Christiansen in order to review the current major barriers to expand adoption of coronary physiology, to discover the advantages of the OptoWire III pressure guidewire in overcoming part of these barriers supporting in full safety the physiology assessments of complex PCI,...

Can a pressure guidewire expand coronary physiology adoption in bifurcations?

Real-world burden of patients with angina undergoing angiography, a population-representative study, FLORIDA

18 May 2021 – From EuroPCR 2021

Watch this session presented by David Leistner in order to learn about a study investigating the long-term burden of patients with angina in a real world cohort, to understand associations between treatment decisions in the catheter laboratory and follow-up interventions, and to know about the kind and frequency...

Real-world burden of patients with angina undergoing angiography, a population-representative study, FLORIDA

RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension

18 May 2021 – From EuroPCR 2021

Watch this session presented by Andrew Sharp in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering...

RADIANCE-HTN TRIO: key takeaways and implications for the treatment of hypertension

Is angio-based FFR ready to replace invasive FFR?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Joost Daemen and Ziad Ali in order to know more about physiological assessment in the cathlab and angio-based vFFR, the results of the multicentre vFFR clinical trial, and the future of angio-based FFR in the cathlab.

Is angio-based FFR ready to replace invasive FFR?

The latest on the prevail drug-coated balloon

18 May 2021 – From EuroPCR 2021

Watch this session presented by Azeem Latib and Antonio Colombo in order to reflect on the latest information on Prevail DCB and study, to explore DCB technology and hear the expert-recommended indications, and to gain insights through an interesting PI case using Prevail DCB.

The latest on the prevail drug-coated balloon

The PASCAL platform: successfully and confidently treating MR

18 May 2021 – From EuroPCR 2021

Watch this session presented by Nicolas van Mieghem, Fabien Praz and Peter Lüdike in order to learn about the PASCAL platform and its differentiated features, to discuss how to identify patients for the treatment with the PASCAL platform, and to review clinical data and discuss patient outcomes...

The PASCAL platform: successfully and confidently treating MR

RADIANCE-HTN TRIO: what does this mean for the treatment of hypertension?

18 May 2021 – From EuroPCR 2021

Watch this session presented by Atul Pathak in order to learn about the recent clinical advancements in the renal denervation procedure with the Paradise Ultrasound RDN system, and to hear the expert's perspective on the recently announced results from RADIANCE-HTN TRIO (blinded, sham-controlled, powered to demonstrate BP lowering...

RADIANCE-HTN TRIO: what does this mean for the treatment of hypertension?

SELUTION DeNovo study: powered to change medical practice

18 May 2021 – From EuroPCR 2021

Watch this session presented by Christian Spaulding in order to gain insight into how the SELUTION DeNovo study could change medical practice, to understand the strategy and what differentiates the SELUTION DeNovo study, and to learn about the study design and key milestones.

SELUTION DeNovo study: powered to change medical practice

The future and vision of intravascular imaging

18 May 2021 – From EuroPCR 2021

Watch this session presented by Nieves Gonzalo in order to highlight the benefits and future of intravascular imaging, to share the benefits of using a structured and streamlined workflow, MLD-MAX, and to understand the benefits of using AI during the crucial steps of PCI.

The future and vision of intravascular imaging

The future of PCI seems bright - The MagicTouch sirolimus-coated balloon

18 May 2021 – From EuroPCR 2021

Watch this session presented by Antonio Colombo, Bernardo Cortese and Sandeep Basavarajaiah in order to understand the strategy behind using a DCB as a proper solution for CAD and the result and potential of using a Sirolimus DCB in coronary intervention, as well as to get insights into real...

The future of PCI seems bright - The MagicTouch sirolimus-coated balloon

Next-Generation Structural Heart Pipeline

18 May 2021 – From EuroPCR 2021

Watch this session presented by Jeffrey Popma and Eberhard Grube to learn more about next-generation Structural Heart Pipeline.

Next-Generation Structural Heart Pipeline

Leading dose solutions for your interventions

18 May 2021 – From EuroPCR 2021

Watch this session presented by Laurent Fieldman in order to understand how innovations can help you optimising dose in your procedures, to learn about latest dose reduction tools for complex interventions, and to review expert perspective on using innovative dose reduction tools.

Leading dose solutions for your interventions

Early real-world experience with Tendyne™ TMVR

18 May 2021 – From EuroPCR 2021

Watch this session presented by Stephan von Bardeleben in order to learn about real-world Tendyne results from TENDER EU, the largest reported commercial cohort, to hear expert feedback on the safety and effectiveness of Tendyne TMVI in real-life setting, and to discover how one heart team integrates Tendyne...

Early real-world experience with Tendyne™ TMVR

EuroPCR 2021: Opening Ceremony - Education & Innovation in Interventional Cardiovascular Medicine

18 May 2021 – From EuroPCR 2021

Did you miss the livestream of EuroPCR 2021’s official Opening Ceremony? Look back to watch the PCR Chairman William Wijns and PCR Vice-Chairman Jean Fajadet launch this innovative edition of the Course. More than ever it was the right place to be!

#EuroPCR 2021 Opening Ceremony
Didn’t find what you were looking for?